Growth hormone (GH) and insulin-like growth factor 1 (IGF1) are important regulators of
bone remodelling and metabolism and have an essential role in the achievement and …

Improving physical function and mobility in a continuously expanding elderly population
emerges as a high priority of medicine today. Muscle mass, strength/power, and maximal …

Purpose Bone is one of the main targets of hormones and endocrine diseases are frequent
causes of secondary osteoporosis and fractures in real-world clinical practice. However …

Growth hormone (GH) and its mediator, the insulin-like growth factor-1 (IGF-1) regulate
somatic growth, metabolism and many aspects of aging. As such, actions of GH/IGF have …

Objective: The aim was to update The Endocrine Society Clinical Practice Guideline on
Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published …

Abstract GH and IGF-I are important regulators of bone homeostasis and are central to the
achievement of normal longitudinal bone growth and bone mass. Although GH may act …

The number of patients surviving≥ 5 years after initial cancer diagnosis has significantly
increased during the last decades due to considerable improvements in the treatment of …

Recent data suggest that anterior pituitary dysfunction after traumatic brain injury (TBI) is
common. We sought to confirm the results of earlier studies in a larger cohort of patients with …

Summary background Pituitary hormone abnormalities have been reported in up to 50% of
survivors of traumatic brain injury (TBI) who were investigated several months or longer …

Background Gender differences in tumor size are supposed to exist in hyperprolactinemia
since microadenomas are more commonly found in women and macroadenomas in men …